This website is intended for an NZ health professional readership
Our brief is broad – if it affects pharmacy its business, staff, patients or ethos, we’re interested. Pharmacy Today provides up-to-date news and education in print and online through your desktop, tablet and mobile.
Published monthly, the magazine provides what print has provided for decades, a relaxing, comprehensive read.
For those readers keen for a daily fix of news, our website is updated daily. And for a weekly summary, our email newsletter, @PharmacyToday, is sent to subscribers every Wednesday, alerting them to the week's news events
At the same time, you can use our world-class learning platform - ELearning - to access our Clinical+Education articles to earn CPD points.
We are here for pharmacy.
Linda Bryant discusses gout, a chronic long-term condition that is often associated with other diseases, and drug-related morbidity and mortality. As such, gout needs to be addressed holistically as part of the psychosocial medical model
Patients can no longer be started on funded selegiline. Patients who were on selegiline prior to 1 August 2021 will need their prescriptions endorsed to receive subsidised supplies. An alternative MAO-B inhibitor, rasagiline, may be a suitable agent for new patients or those transitioning from selegiline.
This resource provides a timeline for the changes and information about transitioning patients from selegiline. Advice on prescribing rasagiline is also included.
